10x Genomics has experienced a significant decline in share price, currently trading around $20 per share, with no bullish indicators for a potential reversal. Recent performance shows growth in total ...
10x Genomics, Inc. (NASDAQ:TXG) shareholders should be happy to see the share price up 15% in the last quarter. But that is meagre solace in the face of the shocking decline over three years. Indeed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback